A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
SUMMARY: In the last decade, an unprecedented genetic diversity has been disclosed among Mycobacterium tuberculosis strains found worldwide. However, well-conserved genotypes seem to prevail in areas with high incidence of tuberculosis. As this may be related to selective advantages, such as advanced mechanisms to circumvent [M. bovis Bacille Calmette–Guerin (BCG)-induced] host defence mechanisms, we investigated the influence of strain diversity on the course of experimental disease. Twelve M. tuberculosis strains, representing four major genotype families found worldwide today, and the laboratory strain H37Rv were each used to infect BALB/c mice by direct intratracheal injection. Compared with H37Rv, infections with Beijng strains were characterized by extensive pneumonia, early but ephemeral tumour necrosis factor-alpha (TNF-α) and inducible isoform of nitric oxide synthetase (iNOS) expression, and significantly higher earlier mortality. Conversely, Canetti strains induced limited pneumonia, sustained TNF-α and iNOS expression in lungs, and almost 100% survival. Strains of the Somali and the Haarlem genotype families displayed less homogeneous, intermediate rates of survival. Previous BCG vaccination protected less effectively against infection with Beijing strains than against the H37Rv strain. In conclusion, genetically different M. tuberculosis strains evoked markedly different immunopathological events. Bacteria with the Beijing genotype, highly prevalent in Asia and the former USSR, elicited a non-protective immune response in mice and were the most virulent. Future immunological research, particularly on candidate vaccines, should include a broad spectrum of M. tuberculosis genotypes rather than a few laboratory strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211
Chomczyński, P. (1993) · PubMed · Cited by 2,788
van Embden, J. D., Cave, M. D., Crawford, J. T., Dale, J. W., Eisenach, K. D., Gicquel, B., Hermans, P., Martin, C., McAdam, R., & Shinnick, T. M. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.2.406-409.1993 · Cited by 2,342
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2243 · Cited by 1,986
Tuberculosis: Commentary on a Reemergent Killer
Bloom, B. R., & Murray, C. J. L. (1992) · Science · doi:10.1126/science.257.5073.1055 · Cited by 1,373
Chan, J., Xing, Y., Magliozzo, R. S., & Bloom, B. R. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.4.1111 · Cited by 1,062
Variations in the NRAMP1 Gene and Susceptibility to Tuberculosis in West Africans
Bellamy, R., Ruwende, C., Corrah, T., McAdam, K. P. W. J., Whittle, H. C., & Hill, A. V. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381002 · Cited by 735
Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia
van Soolingen, D., Qian, L., de Haas, P. E., Douglas, J. T., Traore, H., Portaels, F., Qing, H. Z., Enkhsaikan, D., Nymadawa, P., & van Embden, J. D. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.12.3234-3238.1995 · Cited by 706
Self-citationManca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091096998 · Cited by 595
THE IMMUNOGENETICS OF HUMAN INFECTIOUS DISEASES
Hill, A. V. S. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.593 · Cited by 581
Kremer, K., van Soolingen, D., Frothingham, R., Haas, W. H., Hermans, P. W. M., Martín, C., Palittapongarnpim, P., Plikaytis, B. B., Riley, L. W., Yakrus, M. A., et al. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.8.2607-2618.1999 · Cited by 579
Self-citationvan Soolingen, D., de Haas, P. E., Hermans, P. W., Groenen, P. M., & van Embden, J. D. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.8.1987-1995.1993 · Cited by 489
Self-citationAn Outbreak Involving Extensive Transmission of a Virulent Strain of Mycobacterium tuberculosis
Valway, S. E., Sanchez, M. P. C., Shinnick, T. F., Orme, I., Agerton, T., Hoy, D., Jones, J. S., Westmoreland, H., & Onorato, I. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381001 · Cited by 386
Bifani, P. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530300036037 · Cited by 381
Van Soolingen, D., Hoogenboezem, T., De Haas, P. E. W., Hermans, P. W. M., Koedam, M. A., Teppema, K. S., Brennan, P. J., Besra, G. S., Portaels, F., Top, J., et al. (1997) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-47-4-1236 · Cited by 357
Self-citationGenetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis
Kramnik, I., Dietrich, W. F., Demant, P., & Bloom, B. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150227197 · Cited by 345
Manca, C., Tsenova, L., Barry, C. E., Bergtold, A., Freeman, S., Haslett, P. A. J., Musser, J. M., Freedman, V. H., & Kaplan, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6740 · Cited by 306
Hernández‐Pando, R., Orozcoe, H., Sampieri, A., Pavón, L., Velasquillo, C., Larriva-Sahd, J. A., Varela, J. A., & Madrid, M. V. (1996) · PubMed · Cited by 272
Mycobacterium tuberculosis Beijing Genotype Emerging in Vietnam
Anh, D. D., Borgdorff, M. W., Van, L. N., Lan, N. T. N., van Gorkom, T., Kremer, K., & van Soolingen, D. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0603.000312 · Cited by 249
Self-citationSeah, G. T., Scott, G. M., & Rook, G. A. W. (2000) · The Journal of Infectious Diseases · doi:10.1086/315200 · Cited by 214
CAMINERO, J. A., PENA, M. J., CAMPOS-HERRERO, M. I., RODRÍGUEZ, J. C., GARCÍA, I., CABRERA, P., LAFOZ, C., SAMPER, S., TAKIFF, H., AFONSO, O., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2101031 · Cited by 178
Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice
Huygen, K., Abramowicz, D., Vandenbussche, P., Jacobs, F., De Bruyn, J., Kentos, A., Drowart, A., Van Vooren, J. P., & Goldman, M. (1992) · Infection and Immunity · doi:10.1128/iai.60.7.2880-2886.1992 · Cited by 167
Self-citationHernandez-Pando, R., Pavön, L., Arriaga, K., Orozco, H., Madrid-Marina, V, & Rook, G. (1997) · Infection and Immunity · doi:10.1128/iai.65.8.3317-3327.1997 · Cited by 160
Self-citationHERNANDEZ‐PANDO, R., OROZCO, H., ARRIAGA, E. K., SAMPIERI, A., LARRIVA‐SAHD, J., & MADRID‐MARINA, V. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00193.x · Cited by 147
Self-citationGenetics and Resistance to Tuberculosis: Could Resistance Be Enhanced by Genetic Engineering?
Stead, W. W. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-11-937 · Cited by 135
Schaefer, W. B., Davis, C. L., & Cohn, M. L. (1970) · PubMed · doi:10.1164/arrd.1970.102.4.499 · Cited by 122
Mycobacterium tuberculosisBeijing Genotype Strains Associated with Febrile Response to Treatment
van Crevel, R., Nelwan, R. H. H., de Lenne, W., Veeraragu, Y., van der Zanden, A. G., Amin, Z., van der Meer, J. W. M., & van Soolingen, D. (2001) · Emerging infectious diseases · doi:10.3201/eid0705.017518 · Cited by 121
Novel type-specific lipooligosaccharides from Mycobacterium tuberculosis
Daffé, M., McNeil, M., & Brennan, P. J. (1991) · Biochemistry · doi:10.1021/bi00216a011 · Cited by 111
Portaels, F., Rigouts, L., & Bastian, I. (1999) · PubMed · Cited by 109
Pfyffer, G. E., Auckenthaler, R., van Embden, J. D. A., & van Soolingen, D. (1998) · Emerging infectious diseases · doi:10.3201/eid0404.980414 · Cited by 102
Wangoo, A., Sparer, T. E., Brown, I. N., Snewin, V. A., Janssen, R., Thole, J. E. R., Cook, H. T., Shaw, R. J., & Young, D. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3432 · Cited by 101
Retrospective Analysis of the Beijing Family of Mycobacterium tuberculosis in Preserved Lung Tissues
Qian, L., van Embden, J. D. A., van der Zanden, A. G. M., Weltevreden, E. F., Duanmu, H.-J., & Douglas, J. T. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.2.471-474.1999 · Cited by 93
Hernández‐Pando, R., Schön, T., Orozco, E. H., Serafín‐López, J., & Estrada‐García, I. (2001) · Experimental and Toxicologic Pathology · doi:10.1078/0940-2993-00182 · Cited by 68
Environmental control of tuberculosis
Nardell, E. A. (1993) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30196-1 · Cited by 48
Cited by
Gagneux, S., & Small, P. M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70108-1 · Cited by 712
A robust SNP barcode for typing Mycobacterium tuberculosis complex strains
Coll, F., McNerney, R., Guerra-Assunção, J. A., Glynn, J. R., Perdigão, J., Viveiros, M., Portugal, I., Pain, A., Martin, N., & Clark, T. G. (2014) · Nature Communications · doi:10.1038/ncomms5812 · Cited by 697
Drain, P. K., Bajema, K. L., Dowdy, D., Dheda, K., Naidoo, K., Schumacher, S. G., Ma, S., Meermeier, E., Lewinsohn, D. M., & Sherman, D. R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-18 · Cited by 565
Grode, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24617 · Cited by 557
Cadena, A. M., Fortune, S. M., & Flynn, J. L. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.69 · Cited by 484
Metadata
- Authors
- LÓPEZ, B., AGUILAR, D., OROZCO, H., BURGER, M., ESPITIA, C., RITACCO, V, BARRERA, L., KREMER, K., HERNANDEZ-PANDO, R., HUYGEN, K., & VAN SOOLINGEN, D.
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-24
- Volume
- 133
- Issue
- 1
- Pages
- 30-37
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- OpenAlex
- W2086237232
- Cited by
- 449
- References
- 34
- FWCI
- 15.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.